# Safety and Efficacy Study of Herbal Supplements in Prediabetic and Mild to Moderate Hyperlipidemic Patients

> **NCT01680211** · NA · COMPLETED · sponsor: **Olive Lifesciences Pvt Ltd** · enrollment: 40 (actual)

## Conditions studied

- Prediabetes
- Hyperlipidemia

## Interventions

- **DIETARY_SUPPLEMENT:** Salacia bark extract
- **DIETARY_SUPPLEMENT:** Salacia leaf extract
- **DIETARY_SUPPLEMENT:** Sesame seed extract
- **BEHAVIORAL:** TLC
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT01680211
- **Lead sponsor:** Olive Lifesciences Pvt Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-04
- **Primary completion:** 2012-06
- **Final completion:** 2012-06
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2012-09-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01680211

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01680211, "Safety and Efficacy Study of Herbal Supplements in Prediabetic and Mild to Moderate Hyperlipidemic Patients". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01680211. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*